Privigen® (Intravenous Immunoglobulin (IVIG))

• Brand name: Privigen^®
• Generic name: Intravenous Immunoglobulin (IVIG)
• Indication:

• Replacement therapy in

• Primary immunodeficiency syndromes (PID) such as:

- congenital agammaglobulinaemia and hypogammaglobulinaemia

-common variable immunodeficiency

-severe combined immunodeficiency

-Wiskott-Aldrich syndrome

• Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
• Children with congenital AIDS and recurrent infections

• Immunomodulation

• Immune thrombocytopenic purpura (ITP) in children or adults at high risk of bleeding or prior to surgical interventions to correct the platelet count
• Guillain-Barré syndrome
• Kawasaki disease
• Chronic inflammatory demyelinating polyneuropathy (CIDP)

• Allogeneic bone marrow transplantation

• Dosage form:

• Solution for infusion (10%), for intravenous use only, Vial, 2.5g, 25ml
• Solution for infusion (10%), for intravenous use only, Vial, 5g, 50ml
• Solution for infusion (10%), for intravenous use only, Vial, 10g, 100ml

• Manufacturer: CSL Behring AG
• Country of origin: Switzerland